Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting

Real‐world dosing and titration of parenteral (subcutaneous, SC; intravenous, IV) prostacyclin, a mainstay of pulmonary arterial hypertension (PAH) treatment, is not always consistent with prescribing information or randomized trials and has yet to be adequately characterized. The current study desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Vijay P., Safdar, Zeenat, Sketch, Margaret R., Broderick, Meredith, Nelsen, Andrew C., Lee, Dasom, Melendres‐Groves, Lana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052964/
https://www.ncbi.nlm.nih.gov/pubmed/35506102
http://dx.doi.org/10.1002/pul2.12016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052964/
https://www.ncbi.nlm.nih.gov/pubmed/35506102
http://dx.doi.org/10.1002/pul2.12016

Ejemplares similares